Akili, Inc. (AKLI) は上場企業です ヘルスケア セクターの Medical - Healthcare Information Services 業界で事業展開. 本社所在地は Boston, MA, アメリカ. 現CEOは Matthew Franklin.
AKLI を有する IPO日 2021-06-30, 68 名の正社員, に上場 NASDAQ Capital Marke, 時価総額 $34.1M.
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
